physician-entrepreneur
(10)
Adam Friedman
He took the name from the brightest star in the Scorpius constellation. Now Adam Friedman is betting a Boston biotech, and up to $1.9 billion in deals, on drugging the targets everyone else called impossible.
Tuyen Ong
Tuyen Ong is a physician-turned-biotech executive who spent four years as CEO of Ring Therapeutics, the Flagship Pioneering company trying to turn anelloviruses - harmless viruses that already live in nearly everyone - into a redosable delivery system for genetic medicines. Trained as an ophthalmologist at University College London with an MBA from NYU Stern, he built his career on gene therapy for rare eye disease at Nightstar, Biogen, PTC, Bausch & Lomb and Pfizer before betting on a virus most scientists had written off as biological junk. In 2025 he co-founded PharmasMarket, a drug-development consultancy.
Caralynn Nowinski Collens
Caralynn Nowinski Collens is a physician-turned-entrepreneur and the co-founder and CEO of Dimension Bio (formerly Dimension Inx), a Chicago biotechnology company building regenerative therapeutics that give the body a blueprint to heal itself. Its BioNidum platform fuses materials science, 3D-printing, and digital manufacturing to turn cells into implantable, tissue-like therapies. Before biotech, she spent eight years co-founding and running UI LABS, the innovation collaborative that launched MxD, the U.S. national hub for digital manufacturing. She trained as an M.D./MBA at the University of Illinois at Chicago and has been recognized on Crain's Forty Under Forty, Tech 50, and Notable Women in STEM lists.
Andrew Le
Andrew Le is the co-founder and CEO of Buoy Health, an AI-driven health navigation platform he started out of Harvard Innovation Labs in 2014 after taking three years off from Harvard Medical School. A physician by training who once researched brain cancer, Le built Buoy to answer one deceptively simple question for people who reach for Google first: when do I actually need to see a doctor? Under his leadership Buoy has raised more than $66 million and reached millions of users, drawing backing from major insurers including Optum, Cigna and Humana.
Justin Norden
Justin Norden is the co-founder and CEO of Qualified Health, an enterprise AI platform helping U.S. health systems deploy generative AI safely, with governance, monitoring, and clinical safeguards built in. A Stanford-trained physician with an MBA, an MPhil in computational biology from Cambridge, and a computer science degree from Carleton, he previously was a partner at GSR Ventures investing in healthcare AI, founded Trustworthy AI (acquired by Waymo), worked on Apple's healthcare team, and teaches AI in medicine at Stanford. In March 2026 Qualified Health raised a $125M Series B led by NEA, bringing total funding to $155M while serving 500,000+ users across systems representing roughly 7% of U.S. hospital revenue.
Priyanka Agarwal
Priyanka Agarwal is a physician-turned-founder building HealthEx, an AI-powered patient consent and data-rights platform she started in 2022. A practicing UCSF telehealth physician with an MD from Harvard Medical School and an MBA from Harvard Business School, she is rebuilding how patients grant, revoke, and direct access to their own medical records. HealthEx raised $14M led by General Catalyst, connected to national networks through TEFCA, and partnered with MD Anderson, Epic, CLEAR, and athenahealth to make patient-controlled data the default rather than the exception.
Akili Hinson
Akili Hinson is the founder and CEO of Juno Medical, a technology-powered family medical practice he opened in Harlem in April 2020 with three patient rooms. A physician trained at Weill Cornell with an MBA from Columbia and a stint at McKinsey, he set out to build modern, family-centered primary care for what he calls 'the 99%' in neighborhoods that big health systems skip. Juno now runs clinics in Harlem, Brooklyn, East Atlanta, and Tulsa's Greenwood District, backed by a $12M Series A led by NEXT VENTURES and Serena Williams' Serena Ventures. He was named a 2024-2025 Obama Foundation USA Leader.
Scott Roth
Scott Roth is a cardiologist who spent two decades reading echocardiograms before deciding the ICU needed a faster way to see the heart. As founder and CEO of ImaCor, he built hemodynamic ultrasound (hTEE) around the disposable, pencil-thin ClariTEE probe that stays in a patient for up to 72 hours, giving clinicians a live look at cardiac filling and function instead of waiting on lab results. In 2022 ImaCor and Clarius released the Zura Handheld, billed as the world's first handheld TEE system, putting that view in a 22-ounce device.
Si France
Si France, MD is the Founder and CEO of WelbeHealth, a Menlo Park-based healthcare company operating PACE (Program of All-Inclusive Care for the Elderly) programs across California. A physician-entrepreneur with dual MD/MBA degrees from Dartmouth, he previously founded GoHealth Urgent Care, scaling it to 150+ centers before selling to TPG Growth in 2014. At WelbeHealth he pioneered the first four for-profit PACE organizations in the United States, building a model that enables low-income, medically frail seniors to remain in their homes and communities rather than enter nursing facilities - while saving taxpayers $10,000 per patient annually.
Dan Riskin
Dan Riskin is a physician-entrepreneur, trauma surgeon, and healthcare AI executive who founded Verantos in 2015 to generate high-validity real-world evidence from messy clinical data. A serial innovator who began coding at age 5 and sold software at 12, Riskin holds an MD from Boston University and an MBA from MIT, is board-certified in four specialties, and serves as Clinical Professor of Surgery at Stanford. His prior company Health Fidelity was acquired for more than $150 million. Today, Verantos powers regulatory and reimbursement decisions for major pharmaceutical companies by turning fragmented EHR data into research-grade evidence at scale.